Enzo Biochem, Inc.
Enzo Biochem, Inc. (ENZB) Revenue
Annual & quarterly revenue history · segment & region breakdown
ENZB · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsEnzo Biochem, Inc. trailing twelve-month (TTM) revenue is $0.03B, an increase of 2.72% year-over-year from $0.03B in FY2024.
Revenue trend
2024 – 2005 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-07-31 | $0.03B | +$0.00B | +2.72% |
| 2023-07-31 | $0.03B | -$0.08B | -70.99% |
| 2022-07-31 | $0.11B | -$0.01B | -9.05% |
| 2021-07-31 | $0.12B | +$0.04B | +54.87% |
| 2020-07-31 | $0.08B | -$0.01B | -6.34% |
| 2019-07-31 | $0.08B | -$0.02B | -22.48% |
| 2018-07-31 | $0.10B | -$0.00B | -2.87% |
| 2017-07-31 | $0.11B | +$0.01B | +4.90% |
| 2016-07-31 | $0.10B | +$0.01B | +5.30% |
| 2015-07-31 | $0.10B | +$0.00B | +1.72% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Enzo Biochem, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Enzo Biochem, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Enzo Biochem, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ENZB revenue · 4 questionsENZB's trailing twelve-month (TTM) revenue is $0.03B. That is an increase of 2.72% year-over-year from $0.03B in FY2024.
▸ Source: FMP · Enzo Biochem, Inc. SEC filings · GAAP · Enzo Biochem, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026